top of page

Farmas

Farmas

Farmas is an official partner of Merz Aesthetics in Ukraine.

The Merz Pharma Group is a private family-owned company founded in 1908 by the pharmacist and chemist Friedrich Merz. The core areas of its business activity are neurology and aesthetic medicine. 

Merz Pharma Group is known for its brands that improve the patients' quality of life every day. 

Merz Aesthetics is the innovation leader in the fast-growing aesthetic medicine industry. The company is fully engaged in the research, development and distribution of innovative products in the field of aesthetic medicine and dermatology. 

Farmas, in partnership with Merz, is the founder of an innovative educational project for neurologists, traumatologists, orthopaedists, rehabilitation therapists, and physical therapists – the Farmas Neuro School of Botulinum Toxin Therapy (Next Level). 

Our partners

Logo_Merz-2.png

Merz is an international family-owned company with a 110-year history of success with botulinum toxin therapy and aesthetic medicine as its key focus areas. Innovation, co-operation and trust are the cornerstones of Merz's operation. The company's desire to help people look better, feel better and live better allows for building trust-based relationships with partners and patients. 


1953 First anti-wrinkle preparation 

1964 Merz Special Dragees 

1970 Parkinson's disease treatment – PK-Merz 

2002 Alzheimer's disease treatment – Memantine 

2005 New generation of botulinum toxin – Xeomin 

2010 Merger with Bioform Medical 

2013 Merger with Neocutis & Anteis 

2014 Merger with Ulthera Inc. 

BTI Biotechnology Institute is a Spanish multinational biomedicine and biotechnology company focused on two areas: regenerative medicine and oral implantology. 

BTI is the world-level leader in regenerative medicine using Endoret® (prgf®) technology in various fields of medicine. 

Logo.png.webp

bti

PRP-2.png

Japan Bio Products Со., Ltd. was founded in 1954. Using the latest Japanese technologies, JBP has developed medical devices that help us continue improving our patients' quality of life. 

Using Japanese precision metal cutting/polishing technology, JBP successfully enlarged the inner diameter of needles and cannulas while keeping the outside diameter unchanged, which allowed doctors to use thinner needles and cannulas for cosmetic injections. 

JBP® 

PharmaResearch Products Co., Ltd. is an innovative South Korean biopharmaceutical company that specializes in the research and development of medicinal agents for regenerative medicine using advanced biotechnologies based on natural ingredients. 

PharmaResearch Products Co., Ltd. was founded in 1993. Since 2008, the company has held a leading position as a developer and manufacturer, using its own proprietary DNA fragment optimization technology (DOT™), medicinal agents based on polynucleotides and polydeoxyribonucleotides for tissue regeneration used in various fields of medicine, including aesthetic medicine.

Our products

Botulinum toxin

2__1.png
x001.png-2.webp

Innovative botulinum toxin type A free of complexing proteins (reference 1). It is designed to maintain long-term treatment efficacy and safety (reference 2). 

Xeomin (incobotulinumtoxin A), was developed and manufactured by Merz Pharma GmbH, Dessau, Germany, using advanced technologies for purification and the creation of efficient preparation. 

It is the only neurotoxin that can be transported and stored at room temperature until reconstituted (references 3, 4). Since Xeomin does not contain complex proteins, the risk of neutralizing antibody development is reduced, as well as the risk of botulinotherapy ineffectiveness (references 5, 6). 

The unique process of incobotulinumtoxin A purification by multistage chromatography limits the possibility of denaturation, degradation and biological deactivation of botulinum toxin. 

Advantages:

  • has low immunogenicity

  • in long-term use, potentially reduces the risk of antibody formation 

  • proved safety in the use of high total doses 

  • flexible injection intervals 

  • does not require compliance with the cold chain – convenient transportation and storage conditions (<25 ° С) 

  • approved in more than 73 countries across the globe 

  • FDA and EMEA approved 

  • safety and efficacy confirmed by numerous clinical trials 

New_Lidocaine3_-_.png-2.webp
4x-2.png

Radiesse® is a filler, the major constituent of which is calcium hydroxyapatite that provides a triple mechanism of action (references 1, 2, 3, 4, 5, 7, 8):

1 - Vertical lifting
2 - Contour restoration 
3 - Neocollagenogenesis 

With Radiesse® you will get immediate visible results, lasting up to 12 months (references 6, 7), and the high elasticity and viscosity of the product means that Radiesse® stays at the injection site and provides better lifting with less volume (reference 2) 

Treatment areas (reference 1): 

Volume recovery: 

  • cheekbones 

  • cheeks 

  • chin 

  • rejuvenation of hands 

Contour restoration and mandibular angle reshaping

Volume recovery: 

  • nasolabial folds 

  • horizontal chin line 

Skin quality improvement and whole face lifting

1.gif
Merz_Belotero_Range_.png.webp

Belotero® is the first monophasic hyaluronic acid-based filler synthesized according to the CPM technology (cohesive [homogeneous] polydensified [zones with different densities] matrix [cross-linking structure]) (reference 1, 2).

The unique CPM technology of the Belotero® filler lines provides for a two-step process of HA molecule stabilization and obtaining a monophasic gel with areas of different density. (reference 3). 

Belotero® line fillers, administered as mono- or combined therapy, allow choosing the optimal aesthetic solution for each patient with consideration to the structural and functional characteristics of the skin.

Benefits (references 3, 4, 5, 6)

  • Natural integration and filling of the smallest spaces in the dermis by using the unique CPM technology 

  • Does not cause damage or structural changes to the skin 

  • Easy injection 

  • Optimal safety and tolerability profile 

  • The only filler that can be injected superficially using the blanching technique 

  • Effect duration: 6-12 months 

REJURAN_1_-_.png
Rejuran-2.png

REJURAN - is a new generation of polynucleotides. It restores the youthfulness and health of the skin by enriching it with nucleotides and triggering self-repair mechanisms.

Rejuran® Fillers are the new generation of polynucleotides. They restore skin youthfulness and health by enriching it with nucleotides and triggering self-repair mechanisms

  • Rejuran® Нealer 

  • Rejuran® s 

  • Rejuran® i 

Rejuran® Skin Boosters  - contain a high concentration of polydeoxyribonucleotides (c-PDRN®), which enhance the effect of basic skin care. 
 

  • Rejuran® Skin Booster (to nourish and restore sheen to dull, tired skin) 

  • Rejuran® Tone-Up Booster (a booster for lightening the skin and strengthening its protective barrier) 

  • Rejuran® Skin Booster (для живлення і повернення сяйва тьмяній, втомленій шкірі) 

  • Rejuran® Tone-Up Booster (бустер для освітлення шкіри і посилення її захисного бар'єру) 

Rejuran® Clinic line is a premium cosmetic brand created by Pharma Research Products Co., Ltd., a biopharmaceutical company with many years of experience and knowledge in anti-ageing and regenerative medicine. The company's production facilities that manufacture these cosmetic products are located in the Republic of Korea and the United States. 

Thanks to the patented DNA fragment optimization technology (DOTTM) used in the process of injectable product manufacturing, the company has created the c-PDRN® (cosmetic-PDRN, polydeoxyribonucleotides for cosmetic use) formula. 

sld01_-_.png.webp

Endoret®

Plasma therapy ENDORET PRGF

ENDORET - Natural Regenerative PRGF Technologies – Plasma Rich in Growth Factors ENDORET (PRGF) from BTI (Spain)

Endoret – PRGF Technology (PRGF – Plasma Rich in Growth Factors) is an innovator in the clinical use of platelet-rich plasma (PRP). This technology is a new era of the popular method of plasmolifting or PRP (Platelet Rich Plasma) – platelet-rich plasma. It is fully compliant with the criteria that allow getting P-PRP (Pure PRP). 

With the help of the Endoret plasma therapy (prgf) technique, it is possible to separate, concentrate and obtain growth factors – blood proteins responsible for natural tissue regeneration. 

New_Ultherapy_Logo_b.png
oblique-with-amplify.png

Ultharapy® is a revolutionary non-invasive microfocal ultrasound SMAS lifting technology. Ultherapy® ensures optimal results for the patient: 

  • See specific tissue layers for safe and effective treatment

  • Customize treatments based on the unique anatomy of each patient 

  • Control the direction of energy to the desired depth with a certain temperature to initiate neocollagenesis 

  • Treat certain, most perceptive areas without surgery 

Ultherapy® is approved by experts and confirms the great demand among patients

Logo_Farmas.png

Neuroschool botulinum therapy Farmas (Next level) 

Farmas Neuro School of Botulinum Toxin Therapy (Next Level). 

This project, combining theoretical and practical training, has a stepped structure, taking into account the specialists' competence levels and needs. Leading national and foreign experts are involved in teaching at the School. 

Снимок экрана 2022-05-19 в 17.14.54.png

Academy of Advanced Aesthetics

Academy of Advanced Aesthetics offers the opportunity for training using evidence-based therapies with a high safety profile. A wide portfolio of treatments includes all categories of aesthetic cosmetology products and allows to meet the needs of patients of any age. 

The academy's trainers are highly skilled and clinically experienced professionals with a deep desire to share their knowledge. All trainers of the Academy of Advanced Aesthetics have these professional qualities. 

At the AAA seminars, experts share their practical skills of many years of experience in aesthetic cosmetology, as well as knowledge gained at cadaver courses, international congresses and numerous training sessions conducted specifically for the team of the trainers at the Academy of Advanced Aesthetics. 

FARMAS UAB

Limited Liability Company "Farmas" 
USREOU 304430002, 
Lithuania, city Vilnius, street Svitrigailos, 11K-109 

anna.shemetyllo@farmas.one 

bottom of page